消瘤丸治疗子宫肌瘤(气滞血瘀证)的临床的的研究

《消瘤丸治疗子宫肌瘤(气滞血瘀证)的临床的的研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、新疆医科大学硕士学位论文Xiaofiupilltreatmentoful疵fibroids(bloodstasistype)oftheclinicaleffectsofl'ost鲫uate,MaRongSupervisor：Pl'o￡ChengHuilianAbstractObjective：Toeliminatetumorpilltreatmentofuterinefibroids(bloodstasistype)clinicalobservationandevaluation．Methods：Uterinefibroidshavebeendiagnosed60pa

2、tients，30patientsWel'erandomlydividedintotwogroups，oralconsumptionPill；controlgroupof30patients，lookingforwardtotherapy．3monthsforacourseoftreatmen_t，patientswereobservedandrecordedchangesinclinicalsymptomsandsigns．Beforeandaftertreatmentwe他monitoredbyB—uterineandmyomasize，measuredinliv

3、er,kidney,andChinesemedicinesymptomscoringrecord．Uterinefibroidsbeforeandaftertreatmentandchangesinsize，liverandrenalfunction,嬲well弱traditionalChinesemedicineintreatingsymptomsbeforeandafterthescoring．Results：Theclinicalobservationshowedthattheclinicalrecovery‘ofthetreatmentgroupis2c嬲es

4、，effectivein1C．glSe$，12casesofeffectiveandineffectivein5cases，thetotaleffectofthetotaleffectiverateWaS83．33％andcontrolgroupareclinichealed0cases，effectivein7cases，effectivein8patients，15c嬲esineffective，thetotaleffectofthetotaleffectiverateW'dS50．00％，twogroupstotaleffectivefibroidssignif

5、icantdifferencethatthetreatmentgroupthaninthecontrolgroup，thetreatmenteffect．Pill-tumoreffectofremovingttlmOl"shrinkagethanthecontrolgroup，theaveragetumorvolumebeforetreatmentW-aS：7．17±4．49em3，aftertreatmenttheaveragetumorvolumeof5．67±4．22ern3；controlgroup，meantumorvolumebeforetreatment

6、was8．60+6．04era3，theaveragetumorvolumealtertrealment13．70+8．64era3(p．o．05)．PillConsumers啪improvemcnstnlalperiod,bycolor,byvolume，thequality，andlowerabdominalbulge，abdominalpain,breasttcnderlless,thenthecontrolgroupimprovedonlyslightlymitigateormensmmtion．Accordingtothetreatmentgroupandc

7、ontrolgroupbeforeandaftertreatmentliverfunction,renalfunctionresultswerewithinnormalrange，indicatingthatremovingIUlllOI"pillssafenon-toxic，non-toxicsideeffectsandadversereactions,long-termuse．Conclusion：Thetreatmentofuterinefibroidpilltumorelimination(bloodstasistype)issafeande